Navigation Links
SeraCare Life Sciences Goes Live With SAP
Date:8/8/2013

Milford, MA (PRWEB) August 08, 2013

SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, completed its implementation of SAP® enterprise resource planning (ERP) software. The SAP® system integrates the company’s inventory planning and control, purchasing, production management, quality management and financial reporting systems into a single software solution.

“Our deployment of SAP® delivers greater insight into day-to-day processes and facilitates data-driven forecasting and planning,” said Charles Mamrak, CEO of SeraCare. “SAP will enable us to better meet customer needs with faster, more accurate information about product availability, product specifications, order tracking, and more.”

The investment in SAP® is one of many improvements to the company’s business processes that have been implemented over the last year as the new management team focuses on building a solid platform for growth as a leader in life science tools focused on the diagnostic market. At the beginning of this year, SeraCare reorganized into three market-focused business units serving diagnostic company researchers, manufacturers and clinical laboratories. These fully staffed business units bring focused products and a wealth of experience spanning the diagnostic product development cycle from concept to clinic. The enhanced software systems will provide an even better customer experience going forward.

About SeraCare Life Sciences, Inc.

SeraCare, a portfolio company of Linden Capital Partners, works with diagnostics researchers, IVD manufacturers and clinical laboratories to shape the future of medical diagnostics. Our innovative portfolio includes ACCURUN® quality controls, AccuTrak™, AccuSpan™, AccuSet™ and AccuVert™ panels, SeraCon™ processed plasma, specialty human blood products and Complete BioCollections™ materials. SeraCare helps bridge the gap between today’s diagnostic solutions and tomorrow’s emerging technologies for molecular diagnostics, next generation sequencing, and companion diagnostics. For more information, visit http://www.seracare.com/.

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently has investments in middle market platforms in the products, distribution, and services segments of healthcare. For additional information about Linden, please refer to the firm's website at http://www.lindenllc.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11008427.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
2. SeraCare Shareholders Approve Acquisition by Linden Capital Partners
3. SeraCare Life Sciences Sharpens Focus on Diagnostics Industry
4. SeraCare Life Sciences Divests Biorepository Business
5. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
6. Anti-Toxoplasma Performance Panel from SeraCare Provides Broad Sample of New, Challenging Material
7. Garage Start-ups Now Possible in Life Sciences Industry
8. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
9. DiaTech Life Sciences Announces Medical Advisory Board
10. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
11. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/26/2019)... (PRWEB) , ... October 24, 2019 , ... ... investment in Bichsel Medical Marketing Group (BMMG), a boutique healthcare-specific marketing ... the offerings of its in-house Healthcare Strategy Division. , Healthcare clients in pharma, ...
(Date:10/22/2019)... ... ... Catalent, a global leader in clinical supply services, today announced that Ann ... a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and ... Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at 8:30 a.m., ...
(Date:10/22/2019)... ... October 22, 2019 , ... DermBiont, a clinical stage ... DBI-001, met its primary safety endpoints, with no application site reactions and no ... the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the trial demonstrated a ...
(Date:10/17/2019)... ... October 16, 2019 , ... ... web-based genetic counseling information, has published a new white paper that explores how ... provides guidance as to how patients and medical providers can be kept informed ...
Breaking Biology Technology:
(Date:11/9/2019)... ... November 08, 2019 , ... ... form the leading provider of specialized histology, pathology, biomarker development, and archiving ... recently created by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path ...
(Date:11/6/2019)... ... 06, 2019 , ... NDA Partners Chairman Carl Peck, ... with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert in ... joined the firm as an Expert Consultant. , Dr. Stanski has served in ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... version 2.0 today. The Genomic Search Engine now includes the ability to ... will further accelerate diagnosis of patients with genetic and rare diseases. , Patients, ...
Breaking Biology News(10 mins):